Back to search

Article

Building a resilient antibiotic market An econometric modelling approach to estimating revenues for a novel, broad-spectrum intravenous antibiotic

2026-03-22

Abstract excerpt

India faces a mounting health crisis from antibiotic resistance, coupled with global pharmaceutical hesitancy to invest in novel antibiotic research and development (R&D), driven by complex scientific and financial hurdles. India carries one of the worlds largest absolute burdens of drug-resistant infections. The combination of a huge infectious-disease caseload, rapid urbanisation, and gaps in sanitation and prim...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f92fab01-f785-5848-b640-100721b99b18
DOI
10.64898/2026.03.13.26348309
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Building a resilient antibiotic market An econometric modelling approach to estimating revenues for a novel, broad-spectrum intravenous antibioticDOI 10.64898/2026.03.13.26348309
Health-system drivers of outpatient antibiotic use: evidence from prescribing, centralized supply, and catchment populations in public tertiary hospitals in Bihar, IndiaSemantic proximity
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity
Understanding Antibiotic Purchasing Practices in Community Pharmacies in Bangladesh: A Potential Driver of Emerging Antimicrobial ResistanceSemantic proximity
The Direct Economic Disease Burden of Healthcare-associated Infections (HAIS) and Antimicrobial Resistance (AMR): A Preliminary Study in a Teaching Hospital of NepalSemantic proximity
Differences in the cost of manufacturing pharmaceuticals in India for differently regulated markets: A comparative analysisSemantic proximity
Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity
Global pricing of AWaRe (Access, Watch, Reserve) antibiotics: implications of the UNGA-AMR 70% Access target on national pharmaceutical expenditureSemantic proximity
Identification of publicly available data sources to inform the conduct of Health Technology Assessment in IndiaSemantic proximity
Prescribing trends-branded versus unbranded generics and rational use of medicine at public health facilities in Maharashtra, IndiaSemantic proximity
Publicly Funded Health Insurance in India and its Impact on the Quality of Healthcare: A Scoping Review with a Focus on PM-JAYSemantic proximity
An intersectional study of poverty, migration, and treatment seeking behaviour on antimicrobial use in a semi-urban area in Tamil Nadu, IndiaSemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
Select a neighboring publication to make it the new centre.